Literature DB >> 19482419

Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells.

Silvia Jansen1, Maria Andries, Katrien Vekemans, Hubert Vanbilloen, Alfons Verbruggen, Mathieu Bollen.   

Abstract

Autotaxin, also known as NPP2 (nucleotide pyrophosphatase/phosphodiesterase 2), is a secreted lysophospholipase-D that generates lysophosphatidic acid and thereby promotes the metastatic and invasive properties of tumor cell as well as angiogenesis. We show here that, in mice, NPP2 is cleared from the circulation within minutes and is retained by the liver sinusoidal endothelial cells (LSECs). The binding of NPP2 to isolated LSECs resulted in its degradation and could be competed for with ligands of the scavenger receptor family. Our finding that circulating NPP2 has a rapid turnover has important implications for its development as an anti-cancer target. 2009 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482419     DOI: 10.1016/j.canlet.2009.04.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  33 in total

Review 1.  Liver metastases: Microenvironments and ex-vivo models.

Authors:  Amanda M Clark; Bo Ma; D Lansing Taylor; Linda Griffith; Alan Wells
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

2.  Autotaxin inhibitors: a perspective on initial medicinal chemistry efforts.

Authors:  Abby L Parrill; Daniel L Baker
Journal:  Expert Opin Ther Pat       Date:  2010-11-04       Impact factor: 6.674

Review 3.  Cutting-edge issues in primary biliary cirrhosis.

Authors:  Marco Folci; Francesca Meda; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 4.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

Review 5.  Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.

Authors:  Mari Gotoh; Yuko Fujiwara; Junming Yue; Jianxiong Liu; SueChin Lee; James Fells; Ayako Uchiyama; Kimiko Murakami-Murofushi; Stephen Kennel; Jonathan Wall; Renukadevi Patil; Renuka Gupte; Louisa Balazs; Duane D Miller; Gabor J Tigyi
Journal:  Biochem Soc Trans       Date:  2012-02       Impact factor: 5.407

Review 6.  Lysophospholipid mediators in the vasculature.

Authors:  Paul Mueller; Shaojing Ye; Andrew Morris; Susan S Smyth
Journal:  Exp Cell Res       Date:  2015-03-28       Impact factor: 3.905

7.  Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation.

Authors:  Harald M H G Albers; Anping Dong; Laurens A van Meeteren; David A Egan; Manjula Sunkara; Erica W van Tilburg; Karianne Schuurman; Olaf van Tellingen; Andrew J Morris; Susan S Smyth; Wouter H Moolenaar; Huib Ovaa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-01       Impact factor: 11.205

Review 8.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 9.  Autotaxin: structure-function and signaling.

Authors:  Anastassis Perrakis; Wouter H Moolenaar
Journal:  J Lipid Res       Date:  2014-02-18       Impact factor: 5.922

Review 10.  Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance.

Authors:  Konstantinos A Paschos; Ali W Majeed; Nigel C Bird
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.